← Leaderboards
Walter W Chen
Harvard Medical School
$311,904
Attributed
$311,904
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $168.9K · FY2013–25$200K$150K$100K$50K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$311,904 · 2
By mechanism
K08$168,876 · 1
F30$143,028 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard Medical School
Same institution · by research overlap
- Steven P Gygi$23,279,525
- Edward Leo Huttlin$2,164,077
- Catherine Elizabeth Newman$129,370
- Hao Wu$47,906,316
- Michelle L Stewart$53,724
Others in their field
Top investigators on “Physiology”
- John M Lachin · George Washington University$136,828,043
- David Heimbrook · Leidos Biomedical Research, Inc.$124,943,948
- David M Nathan · Massachusetts Institute Of Technology$120,651,895
- Garret A Fitzgerald · University Of Pennsylvania$103,272,881
- James D Crapo · University Of Colorado Denver$97,173,539
- Monte Westerfield · University Of Oregon$67,958,715
Research focus
PhysiologyFunctional DisorderMouse ModelPlayCellsGenesKnock-OutMitochondrial ProteinsPhysiologicalBiologyElectron TransportPathologyMitochondrial DysfunctionMitochondriaDopaminergic NeuronAntimycinEffective TherapyAge RelatedCharacteristicsDisease ResistanceCessation Of LifeBiological ProcessDefectCell Survival
Grant awards (4)
Investigating an uncharacterized mitochondrial protein in cellular and hepatic physiology$168,876
K08 · FY2025 · DK · contact PI
ATPIF1 inhibition as a therapeutic strategy for mitochondrial dysfunction$48,120
F30 · FY2015 · AG · contact PI
ATPIF1 inhibition as a therapeutic strategy for mitochondrial dysfunction$47,676
F30 · FY2014 · AG · contact PI
ATPIF1 inhibition as a therapeutic strategy for mitochondrial dysfunction$47,232
F30 · FY2013 · AG · contact PI